91亚色传媒

The National Academy of Inventors recently announced its 2023 class of fellows, which includes four 91亚色传媒 Members: Ana Jaklenec, James Janetka, Fred Kramer and Niketa Patel. The fellows will be honored at the NAI Annual Meeting in Raleigh, North Carolina, in June.

Ana Jaklenec

James Janetka

Fred Kramer

Niketa Patel

Jaklenec is a principal research scientist and principal investigator at the David H. Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology. Her lies at the intersection of materials science and immunology. Jaklenec’s current projects include developing single-injection self-boosting vaccines, 3D printed on-demand microneedle vaccines and long-term drug delivery systems for cancer immunotherapy. She is an elected fellow of the American Institute for Medical and Biological Engineering College and the Controlled Release Society.

Janetka is a professor of biochemistry and molecular biophysics at Washington University School of Medicine in St. Louis. His focuses on drug discovery projects that combine biochemistry, structure-based design and synthetic medicinal chemistry to develop peptidomimetic, glycomimetic and small molecule inhibitors. The lab is developing inhibitors of proteases, kinases, lectins, and G-protein coupled receptors as drugs to treat cancer, bacterial and viral infections, and parasitic diseases. Janetka is a co-founder of Fimbrion Therapeutics, which has a drug for urinary tract infections in human clinical trials.

Kramer is a professor of microbiology, biochemistry and molecular genetics and the associate director of the Public Health Research Institute for Business Development at Rutgers University. His develops sensitive, multiplex polymerase chain reaction assays that use DNA fragments in blood samples to detect and quantitate rare mutations for cancer diagnosis, prognosis and therapy. In 2005, he received the Jacob Heskel Gabbay Award in Biotechnology and Medicine from Brandeis University.  

Patel is a professor of molecular medicine at the University of South Florida. Her  focuses on understanding the molecular mechanisms of obesity and diabetes, and the metabolic pathways underlying neurodegenerative diseases. Current projects include analyzing genetic signatures of adipose-derived stem cells from lean and obese patients as well as mechanisms in wound healing promoted by exosomes derived from adipose stem cells. Patel has twelve patents describing novel treatment strategies and small molecule drugs targeting noncoding RNA. 

“This year’s class of NAI fellows showcases the caliber of researchers that are found within the innovation ecosystem,” Paul R. Sanberg, NAI president, said in a ; he added that all NAI fellows “are creating innovations that are driving crucial advancements across a variety of disciplines and are stimulating the global and national economy in immeasurable ways as they move these technologies from lab to marketplace.”